Skip to content

Clinical-Grade Blood Sampling

TAP® Micro Select takes the pain out of blood sampling

TAP® Micro Select can be used for producing whole capillary blood samples, providing laboratories, clinicians, and patients alike with a wealth of benefits and opportunities.

With high concordance demonstrated with venous blood in many commonly requested tests, TAP® Micro Select is able to deliver a superior and virtually pain-free collection experience for patients1.

Benefits to Clinicians and Laboratories

Achieves high-volume, high-quality blood samples

Users can obtain up to 900µL of whole capillary blood in a virtually painless blood draw2, improving adherence to diagnostic protocols. Blood samples collected with TAP® devices are highly concordant with venous blood for most use cases. For broad-based tests, such as cholesterol, the concordance with venous samples is significant1.

Drives Innovation in Laboratory Services

Virtually painless blood sampling supports emerging innovative healthcare models, such as digital health and telemedicine, that are designed to improve access to early diagnoses and give a competitive advantage to early adopters.

Provides Economic Advantage

TAP® Micro Select is easy to use and does not require a phlebotomist, which can help laboratories maintain continuity and operations during phlebotomist shortages or scheduling complications, as well as help eliminate the need for costly phlebotomy services for blood collections by instead providing patients with a superior, virtually pain-free blood draw experience.

How TAP® Micro Select Works

Traditional blood draw methods like standard needles and lancets cause substantial pain and inconvenience to many patients and pose a significant deterrent to testing in some patient populations. TAP® Micro Select overcomes these barriers thanks to the bladeless microneedle array of our HALO™ Technology.

With microneedles thinner than an eyelash, the HALO™ Technology enables the TAP® Micro Select to deliver a virtually painless blood sampling experience compared to fingerstick, venipuncture, and competitive products3. TAP® Micro Select is FDA 510(k) cleared for use within the United States, and has received CE Marking for at-home and lay-person use within the EU.

  • See how TAP® Micro Select leverages the HALO™ Technology Discover TAP®
  • Discover how the proprietary HALO™ Technology enables virtually painless blood draws Learn More

Latest Research and Highlights

Discover the latest studies and reports published on our devices and solutions

View All
  • July 1, 2024
    Feasibility, reliability and satisfaction of (automated) capillary carcinoembryonic antigen measurements for future home-based blood sampling: the prospective CASA-I study
    Colorectal Disease

    Feasibility of home-based capillary sampling of colorectal cancer marker CEA was demonstrated. TAP was found to be “the most reliable method and is preferred by patients over venipuncture and lancet sampling.” (Erasmus MC)

     Read More
  • April 11, 2024
    Evaluation of a hybrid telehealth care pathway for patients with axial spondyloarthritis including self-sampling at home: results of a longitudinal proof-of-concept mixed-methods study (TeleSpactive)
    Rheumatology International

    TAP was employed to demonstrate the feasibility, high patient acceptance, and overall potential of a scalable axSpA hybrid telehealth care pathway.

     Read More
  • February 19, 2024
    Placental transfer dynamics and durability of maternal COVID-19 vaccine-induced antibodies in infants
    iScience

    TAP devices used to collect blood samples from 2-month-old and 12-month-old infants in Sars-CoV-2 infection risk study

     Read More
View All
References
  1. Citation: Collier, B. B., Brandon, W. C., Chappell, M. R., Kovach, P. M. & Grant, R. P. Maximizing Microsampling: Measurement of Comprehensive Metabolic and Lipid Panels Using a Novel Capillary Blood Collection Device. J. Appl. Lab. Med. jfad066 (2023) doi:10.1093/jalm/jfad066.
  2. Citation: Internal data.
  3. Citation: Internal data.